Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

Eli Lilly surged 58% in 2024, driven by weight-loss drugs and strong earnings. The technical chart shows consolidation. See ...

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

As retail investors flock to Viking Therapeutics, the biotech firm is also catching the eye of billionaire fund managers like ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

According to Grand View Research, the global market for beauty and personal care products is projected to increase at a CAGR ...

• Oakland County Water Resources Commissioner Jim Nash will share information about invasive species and the RainSmart ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

Although Lilly started consistently raising its dividend in 2015, investors should be aware of some details around the schedule of these payments. Every year since then, Lilly announced a hike to its ...